enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pembrolizumab - Wikipedia

   en.wikipedia.org/wiki/Pembrolizumab

   Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. [12] [14] [15] [16] It is administered by slow intravenous ...

3. PD-1 and PD-L1 inhibitors - Wikipedia

   en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors

   Pembrolizumab (Keytruda, formerly MK-3475 and lambrolizumab) was developed by Merck and first approved by the Food and Drug Administration in 2014 for the treatment of melanoma. It was later approved for metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. In 2017, it became the first immunotherapy drug approved for ...

4. List of long term side effects of antipsychotics - Wikipedia

   en.wikipedia.org/wiki/List_of_long_term_side...

   These side effects are serious and some of them are permanent, and many remain a crucial concern for companies and healthcare professionals and substantial efforts are being encouraged to reduce the potential risks for future antipsychotics through more clinical trials and drug development.

5. Merck's Keytruda sets new 5-year survival standard for ... - AOL

   www.aol.com/news/mercks-keytruda-sets-5-survival...

   Keytruda competes with rival drugs from Bristol-Myers Squibb , Roche and others in several types of cancer. Merck's Keytruda sets new 5-year survival standard for advanced lung cancer Skip to main ...

6. Merck's Keytruda combo gets FDA nod for expanded use in ... - AOL

   www.aol.com/news/mercks-keytruda-combo-gets-fda...

   Merck's top-selling drug Keytruda helps the body's own immune system fend off cancer by blocking a protein called PD-1. It has been approved to treat more than ten kinds of cancer.

7. Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market

   www.aol.com/news/mercks-keytruda-picks-pace...

   Merck's (MRK) Keytruda is rapidly gaining strength as a key contributor to the company's top line. The Keytruda development program is also progressing well. Merck's Keytruda Picks Up Pace in ...

8. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

9. Merck's Keytruda Gets FDA Nod for Expanded Use in Lymphoma - AOL

   www.aol.com/news/mercks-keytruda-gets-fda-nod...

   The FDA approves Merck's (MRK) Keytruda for the treatment of adult patients with relapsed or refractory cHL who progress after frontline therapy.